Loading
journalsJournal
Journal of gastrointestinal cancer
A clinical journal for cancers of the digestive tract: oesophagus, stomach, liver, gallbladder, pancreas, bowel and rectum. Read by GI oncologists, surgeons and gastroenterologists.
Also called: J Gastrointest Cancer
Overview
The Journal of Gastrointestinal Cancer is published by Springer Nature and catalogued by NLM from 2007 as a United States journal indexed under Gastrointestinal Neoplasms. The publisher describes it as dedicated to understanding and treating cancers arising in the gastrointestinal tract, publishing clinical and translational research on cancers of the oesophagus, stomach, liver, gallbladder, pancreas, colon, rectum and related organs, together with work on epidemiology, prevention, diagnosis, technology and survivorship. Article types include research papers, state-of-the-art reviews, editorials, case reports and letters to the editor; the journal states that basic science and preclinical studies are no longer accepted. It uses a hybrid publishing model allowing either subscription-based or open access publication.
Publisher
Springer Nature
Scope
gastrointestinal oncology
Access model
hybrid
Founded
2007
ISSN
1941-6628
Similar pages
- JournalClinical colorectal cancer
Shares Anal cancer (squamous cell carcinoma), PubMed & Europe PMC, Oesophageal cancer, Biliary tract cancer (cholangiocarcinoma).
- TargetPTPRD
Shares Small intestine cancer (small bowel adenocarcinoma), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma.
- TargetPTPRC
Shares Anal cancer (squamous cell carcinoma), Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- TargetMAX
Shares Small intestine cancer (small bowel adenocarcinoma), Gastrointestinal stromal tumour (GIST), Colorectal cancer.
- JournalEsophagus
Shares PubMed & Europe PMC, Oesophageal cancer.
- JournalJournal of gastric cancer
Shares PubMed & Europe PMC, Gastric & gastro-oesophageal junction cancer.
- CompanyOncolytics Biotech
Shares Anal cancer (squamous cell carcinoma), Pancreatic ductal adenocarcinoma, Colorectal cancer.
- TargetBIRC6
Shares Anal cancer (squamous cell carcinoma), Hepatocellular carcinoma, Colorectal cancer.
cancers
Anal cancer (squamous cell carcinoma)Biliary tract cancer (cholangiocarcinoma)Colorectal cancerGallbladder cancerGastric & gastro-oesophageal junction cancerGastrointestinal stromal tumour (GIST)Hepatocellular carcinomaOesophageal cancerPancreatic ductal adenocarcinomaSmall intestine cancer (small bowel adenocarcinoma)